Deciphera Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	163.36	134.04	96.15	42.09	25	0	0	0	0
Revenue Growth (YoY)	21.87%	39.41%	128.45%	68.35%	-	-	-	-	-
Cost of Revenue	3.73	8.77	2.93	0.23	0	0	0	0	0
Gross Profit	159.62	125.27	93.22	41.86	25	0	0	0	0
Selling, General & Admin	136.46	120.17	136.25	114.08	68.12	21.21	11.42	5.68	5.14
Research & Development	234.12	187.82	257.04	198.97	157.61	82.89	39.51	20.16	12.48
Operating Expenses	370.58	307.99	393.29	313.05	225.73	104.1	50.94	25.84	17.61
Operating Income	-210.96	-182.72	-300.08	-271.19	-200.73	-104.1	-50.94	-25.84	-17.61
Interest Expense / Income	0	0	0	0	0.07	0.08	0.1	0.11	2.21
Other Expense / Income	-16.45	-4.51	-0.11	-4.7	-8.54	-4.33	-0.75	-0	-0
Pretax Income	-194.51	-178.21	-299.96	-266.49	-192.26	-99.85	-50.28	-25.94	-19.82
Income Tax	0.43	0.72	0	0	0	0	0	0	0
Net Income	-194.94	-178.93	-299.96	-266.49	-192.26	-99.85	-50.28	-25.94	-19.82
Shares Outstanding (Basic)	85	76	58	56	43	35	17	12	4
Shares Outstanding (Diluted)	85	76	58	56	43	35	17	12	4
Shares Change	12.66%	29.98%	4.13%	30.12%	21.13%	110.76%	44.43%	173.84%	-
EPS (Basic)	-2.29	-2.37	-5.16	-4.78	-4.48	-2.82	-2.99	-2.23	-4.67
EPS (Diluted)	-2.29	-2.37	-5.16	-4.78	-4.48	-2.82	-2.99	-2.23	-4.67
Free Cash Flow	-147.48	-153.7	-242.79	-244.99	-154.23	-87.91	-37.11	-23.31	-13.41
Free Cash Flow Per Share	-1.73	-2.04	-4.18	-4.39	-3.60	-2.48	-2.21	-2.00	-3.16
Gross Margin	97.72%	93.46%	96.95%	99.47%	100.00%	-	-	-	-
Operating Margin	-129.14%	-136.32%	-312.10%	-644.36%	-802.90%	-	-	-	-
Profit Margin	-119.34%	-133.49%	-311.98%	-633.19%	-769.02%	-	-	-	-
Free Cash Flow Margin	-90.28%	-114.67%	-252.52%	-582.11%	-616.92%	-	-	-	-
EBITDA	-187.94	-171.14	-293.5	-261.35	-190.4	-99.45	-50.04	-25.74	-17.53
EBITDA Margin	-115.05%	-127.68%	-305.26%	-620.98%	-761.60%	-	-	-	-
Depreciation & Amortization	6.58	7.07	6.46	5.14	1.79	0.32	0.15	0.09	0.07
EBIT	-194.51	-178.21	-299.96	-266.49	-192.19	-99.77	-50.19	-25.83	-17.61
EBIT Margin	-119.07%	-132.96%	-311.98%	-633.19%	-768.76%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).